Fusen Pharmaceutical Company Limited

HK$0.99As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1652Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (8.66%)
Div yield —
ROE (0.68%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.15
PE TTM —
TSR TTM 5.32%
Mkt cap HK$731.9M
ROIC (1.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.987
(0.28%)
(40.13%)
Hold 2|12|4|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
13.28%
16.60%
10.83%
16.11%
Revenue¥M
51.52
50.73
52.20
51.06
9.43%
5.41%
3.24%
(3.60%)
Peers (US$93.36M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.669
(0.089)
(0.049)
EBIT/Intx
0.265
0.079
0.061
Own earn%
(52.47)
(64.17)
(58.93)
Sh yield%
44.79
45.28
45.87
Owners
Insiders/Inst%
12.31
35.02
Short interest%
4.01
SBC / revenue%
3.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
15–21
$1 testx
—
Incr. ROIC%
2